You Should Watch These: Tremor Video, Inc., JA Solar Holdings Co., (NASDAQ:JASO), Ohr Pharmaceutical (NASDAQ:OHRP), Epizyme (NASDAQ:EPZM)

Apple Inc. (NASDAQ:AAPL) shares moved up 1.27% in last trading session and ended the day at $118.78. AAPL Gross Margin is 40.10% and its has a return on assets of 19.70%. Apple Inc. (NASDAQ:AAPL) quarterly performance is 12.79%.

Apple Inc. (NASDAQ:AAPL) has added two new educational profiles to its existing list, reports Apple Insider. These new profiles; Texas’ Coppell High School and Philadelphia’s Performing Arts School, help students learn with the iPad for complex topics such as heart anatomy. The teachers shall use the devices to create customized teaching plans.

Tremor Video, Inc. (NYSE:TRMR) ended the last trading day at $1.85. Company weekly volatility is calculated as 3.35% and price to cash ratio as 1.47. Tremor Video, Inc. (NYSE:TRMR) showed a weekly performance of -5.61%.

Tremor Video, Inc. (NYSE:TRMR)‘s stock had its “hold” rating reiterated by investment analysts at Canaccord Genuity in a report released on Sunday, Market Beat Ratings reports. They presently have a $5.00 price target on the stock. Canaccord Genuity’s price target would suggest a potential upside of 134.74% from the stock’s previous close.

JA Solar Holdings Co., Ltd. (NASDAQ:JASO) caters to the Technology space. It has a net profit margin of 4.10% and weekly performance is 2.68%. On the last day of trading company shares ended up at $8.23. JA Solar Holdings Co., Ltd. (NASDAQ:JASO) distance from 50-day simple moving average (SMA50) is 10.15%.

On 17 November, JA Solar Holdings Co., Ltd. (NASDAQ:JASO) announced its unaudited financial results for its third quarter ended September 30, 2015. Gross profit of RMB 677.5 million ($106.6 million) increased 49.2% y/y and 52.5% sequentially. Gross margin was 17.7%, which compares to 15.0% in the year-ago quarter, and 16.4% in the second quarter of 2015. The y/y and sequential increase in gross margin was primarily due to continued cost reduction efforts combined with lower polysilicon prices and a stable ASP in key markets, including China.

Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) shares moved up 8.07% in last trading session and ended the day at $3.75. OHRP has a return on assets of -46.60%. Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) quarterly performance is 45.35%.

On 16 November, Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) presented additional positive data from the Phase 2 IMPACT study evaluating OHR-102 (Squalamine lactate ophthalmic solution, 0.2%) combination therapy for the treatment of the wet form of age-related macular degeneration (wet-AMD). The data were presented by Dr. David S. Boyer, retina specialist at Retina-Vitreous Associates Medical Group and investigator in the study, at the annual meeting of the American Academy of Ophthalmology (AAO), in Las Vegas.

Epizyme, Inc. (NASDAQ:EPZM) caters to the Healthcare space. Its weekly performance is -7.02%. On the last day of trading company shares ended up at $14.43. Epizyme, Inc. (NASDAQ:EPZM) distance from 50-day simple moving average (SMA50) is 1.21%.

On 9 November, Epizyme, Inc. (NASDAQ:EPZM) reported business highlights and operating and financial results for the third quarter of 2015. Collaboration revenue was $0.4 million in the third quarter of 2015 and $2.0 million for the nine months ended September 30, 2015 compared with $8.2 million and $31.1 million in the comparable periods of 2014.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *